A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain
Source abstract
Abstract
Nanoparticle-mediated drug delivery is especially useful for targets within endosomes because of the endosomal transport mechanisms of many nanomedicines within cells. Here, we report the design of a pH-responsive, soft polymeric nanoparticle for the targeting of acidified endosomes to precisely inhibit endosomal signalling events leading to chronic pain. In chronic pain, the substance P (SP) neurokinin 1 receptor (NK1R) redistributes from the plasma membrane to acidified endosomes, where it signals to maintain pain. Therefore, the NK1R in endosomes provides an important target for pain relief. The pH-responsive nanoparticles enter cells by clathrin- and dynamin-dependent endocytosis and accumulate in NK1R-containing endosomes. Following intrathecal injection into rodents, the nanoparticles, containing the FDA-approved NK1R antagonist aprepitant, inhibit SP-induced activation of spinal neurons and thus prevent pain transmission. Treatment with the nanoparticles leads to complete and persistent relief from nociceptive, inflammatory and neuropathic nociception and offers a much-needed non-opioid treatment option for chronic pain.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Pain Mechanisms and Treatments · Advancements in Transdermal Drug Delivery · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. De Jong, W. H. & Borm, P. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 3, 133–149 (2008).10.2147/IJN.S596 ↗
2. Farokhzad, O. C. & Langer, R. Impact of nanotechnology on drug delivery. ACS Nano 3, 16–20 (2009).10.1021/nn900002m ↗
3. Uhrich, K. E., Cannizzaro, S. M., Langer, R. S. & Shakesheff, K. M. Polymeric systems for controlled drug release. Chem. Rev. 99, 3181–3198 (1999).10.1021/cr940351u ↗
4. Maeda, H. et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control Rel. 65, 271–284 (2000).10.1016/S0168-3659(99)00248-5 ↗
5. Such, G. K., Yan, Y., Johnston, A. P. R., Gunawan, S. T. & Caruso, F. Interfacing materials science and biology for drug carrier design. Adv. Mater. 27, 2278–2297 (2015).10.1002/adma.201405084 ↗
6. Chan, J. M., Farokhzad, O. C. & Gao, W. pH-responsive nanoparticles for drug delivery. Mol. Pharm. 7, 1913–1920 (2010).10.1021/mp100253e ↗
7. Lynn, D. M., Amiji, M. M. & Langer, R. pH-responsive polymer microspheres: rapid release of encapsulated material within the range of intracellular pH. Angew. Chem. Int. Ed. 40, 1707–1710 (2001).10.1002/1521-3773(20010504)40:9<1707::AID-ANIE17070>3.0.CO;2-F ↗
8. Mura, S., Nicolas, J. & Couvreur, P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12, 991–1003 (2013).10.1038/nmat3776 ↗
9. Schmaljohann, D. Thermo- and pH-responsive polymers in drug delivery. Adv. Drug Deliv. Rev. 58, 1655–1670 (2006).10.1016/j.addr.2006.09.020 ↗
10. Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016).10.1038/natrevmats.2016.14 ↗
11. Zhou, K. et al. Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells. Angew. Chem. Int. Ed. 50, 6109–6114 (2011).10.1002/anie.201100884 ↗
12. Nelson, C. E. et al. Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time and bioactivity in vivo. ACS Nano 7, 8870–8880 (2013).10.1021/nn403325f ↗
13. Thomsen, A. R. B., Jensen, D. D., Hicks, G. A. & Bunnett, N. W. Therapeutic targeting of endosomal G protein-coupled receptors. Trends Pharmacol. Sci. 39, 879–891 (2018).10.1016/j.tips.2018.08.003 ↗
14. Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B. & Gloriam, D. E. Trends in GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discov. 16, 829–842 (2017).10.1038/nrd.2017.178 ↗
15. Murphy, J. E., Padilla, B. E., Hasdemir, B., Cottrell, G. S. & Bunnett, N. W. Endosomes: a legitimate platform for the signaling train. Proc. Natl Acad. Sci. USA 106, 17615–17622 (2009).10.1073/pnas.0906541106 ↗
16. Vilardaga, J. P., Jean-Alphonse, F. G. & Gardella, T. J. Endosomal generation of cAMP in GPCR signaling. Nat. Chem. Biol. 10, 700–706 (2014).10.1038/nchembio.1611 ↗
17. Irannejad, R. et al. Functional selectivity of GPCR-directed drug action through location bias. Nat. Chem. Biol. 13, 799–806 (2017).10.1038/nchembio.2389 ↗
18. Stoeber, M. et al. A genetically encoded biosensor reveals location bias of opioid drug action. Neuron 98, 963–976 (2018).10.1016/j.neuron.2018.04.021 ↗
19. Jensen, D. D. et al. Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief. Sci. Transl. Med. 9, eaal3447 (2017).10.1126/scitranslmed.aal3447 ↗
20. Jimenez-Vargas, N. N. et al. Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome. Proc. Natl Acad. Sci. USA 115, E7438–E7447 (2018).10.1073/pnas.1721891115 ↗
21. Yarwood, R. E. et al. Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission. Proc. Natl Acad. Sci. USA 114, 12309–12314 (2017).10.1073/pnas.1706656114 ↗
22. Kramer, M. S. et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281, 1640–1645 (1998).10.1126/science.281.5383.1640 ↗
23. Quartara, L., Altamura, M., Evangelista, S. & Maggi, C. A. Tachykinin receptor antagonists in clinical trials. Expert Opin. Investig. Drugs 18, 1843–1864 (2009).10.1517/13543780903379530 ↗
24. Steinhoff, M. S., Von Mentzer, B., Geppetti, P., Pothoulakis, C. & Bunnett, N. W. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. Physiol. Rev. 94, 265–301 (2014).10.1152/physrev.00031.2013 ↗
25. Manders, E. M. M., Verbeek, F. J. & Aten, J. A. Measurement of co-localization of objects in dual-colour confocal images. J. Microsc. 169, 375–382 (1993).10.1111/j.1365-2818.1993.tb03313.x ↗
26. Robertson, M. J. et al. Synthesis of the PitStop family of clathrin inhibitors. Nat. Protoc. 9, 1592–1606 (2014).10.1038/nprot.2014.106 ↗
27. Robertson, M. J., Deane, F. M., Robinson, P. J. & McCluskey, A. Synthesis of Dynole 34-2, Dynole 2-24 and Dyngo 4a for investigating dynamin GTPase. Nat. Protoc. 9, 851–870 (2014).10.1038/nprot.2014.046 ↗
28. Mantyh, P. W. et al. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 268, 1629–1632 (1995).10.1126/science.7539937 ↗
29. Stein, C., Millan, M. J. & Herz, A. Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds. Pharmacol. Biochem. Behav. 31, 445–451 (1988).10.1016/0091-3057(88)90372-3 ↗
30. Decosterd, I. & Woolf, C. J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87, 149–158 (2000).10.1016/S0304-3959(00)00276-1 ↗
31. Bravo, D. et al. Pannexin 1: a novel participant in neuropathic pain signaling in the rat spinal cord. Pain 155, 2108–2115 (2014).10.1016/j.pain.2014.07.024 ↗
32. Abbadie, C., Brown, J. L., Mantyh, P. W. & Basbaum, A. I. Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience 70, 201–209 (1996).10.1016/0306-4522(95)00343-H ↗
33. Geppetti, P., Veldhuis, N. A., Lieu, T. & Bunnett, N. W. G protein-coupled receptors: dynamic machines for signaling pain and itch. Neuron 88, 635–649 (2015).10.1016/j.neuron.2015.11.001 ↗
34. Halls, M. L. & Canals, M. Genetically encoded FRET biosensors to illuminate compartmentalised GPCR signalling. Trends Pharmacol. Sci. 39, 148–157 (2018).10.1016/j.tips.2017.09.005 ↗
35. Irannejad, R. & von Zastrow, M. GPCR signaling along the endocytic pathway. Curr. Opin. Cell Biol. 27, 109–116 (2014).10.1016/j.ceb.2013.10.003 ↗
36. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).10.1038/nmeth.2019 ↗
37. Zimmermann, M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109–110 (1983).10.1016/0304-3959(83)90201-4 ↗
38. Randall, L. O. & Selitto, J. J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. Ther. 111, 409–419 (1957).
39. Santos-Nogueira, E., Redondo Castro, E., Mancuso, R. & Navarro, X. Randall–Selitto test: a new approach for the detection of neuropathic pain after spinal cord injury. J. Neurotrauma 29, 898–904 (2012).10.1089/neu.2010.1700 ↗
40. Retamal, J. et al. Burst-like subcutaneous electrical stimulation induces BDNF-mediated, cyclotraxin B-sensitive central sensitization in rat spinal cord. Front. Pharmacol. 9, 1143 (2018).10.3389/fphar.2018.01143 ↗
41. Imlach, W. L., Bhola, R. F., May, L. T., Christopoulos, A. & Macdonald, J. C. A positive allosteric modulator of the adenosine α1 receptor selectively inhibits primary afferent synaptic transmission in a neuropathic pain model. Mol. Pharmacol. 88, 460–468 (2015).10.1124/mol.115.099499 ↗
42. Di Porzio, U., Daguet, M. C., Glowinski, J. & Prochiantz, A. Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature 288, 370–373 (1980).10.1038/288370a0 ↗